The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials

Author： Mistry Nisha B Westheim Arne S Kjeldsen Sverre E

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.5, 2006-04, pp. : 575-581

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valsartan: a novel angiotensin Type 1 receptor antagonist

By Thürmann P.A.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 337-350

Informa Healthcare

Access to resources Recommend Favorite

Effect of the Angiotensin II Receptor Antagonist Valsartan on Lipid Profile and Glucose Metabolism in Patients with Hypertension

By Hanefeld M Abletshauser C

The Journal of International Medical Research, Vol. 29, Iss. 4, 2001-07 ,pp. : 270-279

Field House Publishing

Access to resources Recommend Favorite

Substituted Benzimidazole Derivatives as Angiotensin II -AT1 Receptor Antagonist: A Review

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-12 ,pp. : 1366-1384

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction

By Salam Amar M

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 501-507

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Angiotensin II Type 1 Receptor Blocker/Calcium Channel Blocker Combination Therapy for Hypertension: Focus on a Single-pill Fixed-dose Combination of Valsartan and Amlodipine

By Miura S Saku K

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 1-9

Field House Publishing

Access to resources Recommend Favorite